Search results for: sars cov 2

Filter by:

Date range:
From
To
Categories:
Tags:
Authors:

Showing 1 - 10 of 39 results

27 August 2024

Game-changing needle-free COVID-19 intranasal vaccine

A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.

Health + Wellbeing Griffith Health Institute for Biomedicine and Glycomics
Read More
26 July 2023
SARS-CoV-2— the virus that causes COVID-19—isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in a lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Credit: NIAID-RML

Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral

Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.

Business + Government Health + Wellbeing Industry partnerships Menzies Health Institute Queensland School of Pharmacy and Medical Sciences
Read More
14 March 2023

World’s strongest MRI investigates COVID and myalgic encephalomyelitis/chronic fatigue impacts on the brain

In a world-first, Griffith University researchers have used an ultra-high field MRI (7 Tesla) to investigate how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mirror the same effects on the brain structure.

Health + Wellbeing Menzies Health Institute Queensland Students
Read More
15 December 2022
Woman's eye's, wearing a mask
Read More
14 June 2021
COVID 19

Mutations, variants and strains? A guide to COVID-19 terminology

Living through a global pandemic over the past year has seen all of us expanding our vocabularies. We now understand terms like PPE, social distancing and contact tracing. But just when perhaps we thought we had a handle on most of the terminology, we’re faced with another set of new words: mutation, variant and strain.

Health + Wellbeing
Read More
17 May 2021
The COVID-19 antiviral research team Professor Kevin Morris, Dr Adi Idris, Professor Nigel McMillan, Dr Arron Supramanin and Mr Yusif Idres.
Read More
19 April 2021
Evans blue (cyan) is shown bound at the interface between the SARS-CoV-2 Spike (green) and its host receptor ACE2 (grey). Image credit: A/Prof Thomas Haselhorst
Read More
8 March 2021

New research may be key to making safe, durable COVID-19 vaccines

Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19

Health + Wellbeing Institute for Biomedicine and Glycomics Institute for Glycomics UN Sustainable Development Goals
Read More
3 March 2021
Read More
26 February 2021
Microscopy image of the fluorescent SARS-CoV-2 virus (in pink) engineered by Griffith University and University of Tartu researchers showing infected cells.

COVID-19 toolkit to boost vaccine development and research

An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow...

Health + Wellbeing Menzies Health Institute Queensland Research UN Sustainable Development Goals
Read More